Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The hypocretins and the reward function: what have we learned so far?
Benjamin Boutrel, Nadia Steiner, Olivier Halfon
Frontiers in Behavioral Neuroscience (2013) Vol. 7
Open Access | Times Cited: 47

Showing 1-25 of 47 citing articles:

Motivational activation: a unifying hypothesis of orexin/hypocretin function
Stephen V. Mahler, David E. Moorman, Rachel J. Smith, et al.
Nature Neuroscience (2014) Vol. 17, Iss. 10, pp. 1298-1303
Open Access | Times Cited: 358
Hypocretin (orexin) biology and the pathophysiology of narcolepsy with cataplexy
Roland Liblau, Anne Vassalli, Ali Seifinejad, et al.
The Lancet Neurology (2015) Vol. 14, Iss. 3, pp. 318-328
Closed Access | Times Cited: 176
The neurobiology of modafinil as an enhancer of cognitive performance and a potential treatment for substance use disorders
Maddalena Mereu, Antonello Bonci, Amy Hauck Newman, et al.
Psychopharmacology (2013) Vol. 229, Iss. 3, pp. 415-434
Open Access | Times Cited: 139
Orexin in sleep, addiction and more: Is the perfect insomnia drug at hand?
Daniël Hoyer, Laura H. Jacobson
Neuropeptides (2013) Vol. 47, Iss. 6, pp. 477-488
Closed Access | Times Cited: 107
Hypocretin (orexin) neuromodulation of stress and reward pathways
William J. Giardino, Luı́s de Lecea
Current Opinion in Neurobiology (2014) Vol. 29, pp. 103-108
Open Access | Times Cited: 96
Recent perspectives on orexin/hypocretin promotion of addiction-related behaviors
F. Woodward Hopf
Neuropharmacology (2020) Vol. 168, pp. 108013-108013
Open Access | Times Cited: 50
Neurobiology of the Orexin System and Its Potential Role in the Regulation of Hedonic Tone
Martin A. Katzman, Matthew P. Katzman
Brain Sciences (2022) Vol. 12, Iss. 2, pp. 150-150
Open Access | Times Cited: 30
Reducing substance use during adolescence: a translational framework for prevention
Jessica J. Stanis, Susan L. Andersen
Psychopharmacology (2014) Vol. 231, Iss. 8, pp. 1437-1453
Open Access | Times Cited: 61
Hypocretin neuron-specific transcriptome profiling identifies the sleep modulator Kcnh4a
Laura Yelin‐Bekerman, Idan Elbaz, Alex Diber, et al.
eLife (2015) Vol. 4
Open Access | Times Cited: 59
The Neurobiological Mechanisms of Gamma-Hydroxybutyrate Dependence and Withdrawal and Their Clinical Relevance: A Review
Rama Kamal, Martijn S. van Noorden, Ernst Franzek, et al.
Neuropsychobiology (2016) Vol. 73, Iss. 2, pp. 65-80
Open Access | Times Cited: 59
Orexin 1 receptor antagonists in compulsive behavior and anxiety: possible therapeutic use
Emilio Merlo Pich, Sergio Melotto
Frontiers in Neuroscience (2014) Vol. 8
Open Access | Times Cited: 57
Suvorexant for the treatment of insomnia
Laura H. Jacobson, Gabrielle E. Callander, Daniël Hoyer
Expert Review of Clinical Pharmacology (2014) Vol. 7, Iss. 6, pp. 711-730
Closed Access | Times Cited: 52
A sleeping giant: Suvorexant for the treatment of alcohol use disorder?
Erin J. Campbell, Nathan J. Marchant, Andrew J. Lawrence
Brain Research (2018) Vol. 1731, pp. 145902-145902
Closed Access | Times Cited: 50
Orexin-1 receptor blockade suppresses compulsive-like alcohol drinking in mice
Kelly Lei, Scott A. Wegner, Ji-Hwan Yu, et al.
Neuropharmacology (2016) Vol. 110, pp. 431-437
Open Access | Times Cited: 42
Nucleus Accumbens Shell and mPFC but Not Insula Orexin-1 Receptors Promote Excessive Alcohol Drinking
Kelly Lei, Scott A. Wegner, Ji Hwan Yu, et al.
Frontiers in Neuroscience (2016) Vol. 10
Open Access | Times Cited: 41
Appetite hormones, neuropsychological function and methylphenidate use in children with attention-deficit/hyperactivity disorder
Kuan-Yu Lai, Chia‐Jung Li, Ching‐Shu Tsai, et al.
Psychoneuroendocrinology (2024) Vol. 170, pp. 107169-107169
Closed Access | Times Cited: 4
The Hypocretin System and Psychiatric Disorders
Fabio Pizza, Michele Magnani, Camilla Indrio, et al.
Current Psychiatry Reports (2013) Vol. 16, Iss. 2
Closed Access | Times Cited: 40
Smoking, Alcohol, Drug Use, Abuse and Dependence in Narcolepsy and Idiopathic Hypersomnia: A Case-Control Study
Lucie Barateau, Isabelle Jaussent, Régis Lopez, et al.
SLEEP (2016) Vol. 39, Iss. 3, pp. 573-580
Open Access | Times Cited: 38
Hypocretin/orexin deficiency decreases cocaine abuse liability
Nadia Steiner, Clara Rossetti, Takeshi Sakurai, et al.
Neuropharmacology (2018) Vol. 133, pp. 395-403
Open Access | Times Cited: 35
Nucleus Accumbens Shell Orexin-1 Receptors Are Critical Mediators of Binge Intake in Excessive-Drinking Individuals
Kelly Lei, Claudina Kwok, David Darevsky, et al.
Frontiers in Neuroscience (2019) Vol. 13
Open Access | Times Cited: 33
Orexin-mediated Motivated Arousal and Reward Seeking.
Theresa E. Bjorness, Robert Greene
Peptides (2024) Vol. 180, pp. 171280-171280
Closed Access | Times Cited: 3
Inhibition of TrkB at the nucleus accumbens, using ANA-12, regulates basal and stress-induced orexin A expression within the mesolimbic system and affects anxiety, sociability and motivation
Idu Azogu, Hélène Plamondon
Neuropharmacology (2017) Vol. 125, pp. 129-145
Closed Access | Times Cited: 30
The effects of single-dose injections of modafinil and methamphetamine on epigenetic and functional markers in the mouse medial prefrontal cortex: potential role of dopamine receptors
Betina González, Oscar V. Torres, Subramaniam Jayanthi, et al.
Progress in Neuro-Psychopharmacology and Biological Psychiatry (2018) Vol. 88, pp. 222-234
Open Access | Times Cited: 29
Targeting the orexin system for prescription opioid use disorder: Orexin-1 receptor blockade prevents oxycodone taking and seeking in rats
Alessandra Matzeu, Rémi Martin‐Fardon
Neuropharmacology (2019) Vol. 164, pp. 107906-107906
Open Access | Times Cited: 28
Suvorexant maintenance enhances the reinforcing but not subjective and physiological effects of intravenous cocaine in humans
William W. Stoops, Justin C. Strickland, Kevin W. Hatton, et al.
Pharmacology Biochemistry and Behavior (2022) Vol. 220, pp. 173466-173466
Open Access | Times Cited: 15
Page 1 - Next Page

Scroll to top